Bristol-Myers Squibb Company (BMY) Net margin 2016–2025
Bristol-Myers Squibb Company (BMY) net profit margin by fiscal year — reported net income divided by reported revenue.
14.6%FY2025 · since FY2016: 22.9% → 14.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 14.6% | +33.2 pp |
| FY2024 | -18.5% | -36.4 pp |
| FY2023 | 17.8% | +4.1 pp |
| FY2022 | 13.7% | -1.4 pp |
| FY2021 | 15.1% | +36.3 pp |
| FY2020 | -21.2% | -34.4 pp |
| FY2019 | 13.2% | -8.7 pp |
| FY2018 | 21.8% | +17.0 pp |
| FY2017 | 4.8% | -18.1 pp |
| FY2016 | 22.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice